Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: A randomized, controlled study

Chest

Volumn 117, Issue 6, 2000, Pages 1538-1545

  Vardas, Panos E ^a   Kochiadakis, George E ^a   Igoumenidis, Nikos E ^a   Tsatsakis, Aristidis M ^a   Simantirakis, Emmanuel N ^a   Chlouverakis, Gregory I ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Amiodarone; Atrial fibrillation; Cardioversion; Left atrial diameter

Indexed keywords

AMIODARONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHLEBITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINUS RHYTHM;

EID: 0034096364     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.117.6.1538     Document Type: Article

References (22)

1. 1 Pritchett ELC. Management of atrial fibrillation. N Engl J Med 1992; 326:1264-1271
2. 2 Management of patients with atrial fibrillation: a statement for healthcare professionals from the subcommittee on electrocardiography and electrophysiology: American Heart Association. Circulation 1996; 93:1262-1277
3. 3 Nattel S. Newer developments in the management of atrial fibrillation. Am Heart J 1995; 130:1094-1106
4. 4 Falk RH. Current management of atrial fibrillation. Curr Opin Cardiol 1994; 9:30-39
5. 5 Tieleman RG, Gosselink ATM, Crijns HJGM, et al. Efficacy, safety and determinants of conversion of atrial fibrillation and flutter with oral amiodarone. Am J Cardiol 1997; 79:53-57
6. 6 Kerin NZ, Faitel K, Naini M. The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Arch Intern Med 1996; 156:49-53
7. 7 Gosselink ATM, Crijns HJGM, Van Gelder IC, et al. Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. JAMA 1992; 267:3289-3293
8. 8 Hou ZY, Chang MS, Chen CY, et al. Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. Eur Heart J 1995; 16:521-528
9. 9 Levy S. Amiodarone as a first-line drug in the treatment of atrial fibrillation: the protagonist viewpoint. Cardiovasc Drugs Ther 1994; 8:769-771
10. 10 Galve EG, Rius T, Ballester K, et al. Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study. J Am Coll Cardiol 1996; 27: 1079-1082
11. 11 Edvarsson N. Comparison of class I and class III action in atrial fibrillation. Eur Heart J 1993; 14(suppl II):62-66
12. 12 Middlekauff HR, Wiener I, Stevenson WG. Low-dose amiodarone for atrial fibrillation. Am J Cardiol 1993; 72:75F-81F
13. 13 Capucci A, Lenzi T, Boriani G, et al. Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol 1992; 70:9-72
14. 14 Donovan KD, Power BM, Hockings BEF. Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation. Am J Cardiol 1995; 75:693-697
15. 15 Galve C, Rius T, Ballester R, et al. Intravenous amiodarone in treatment of recent onset atrial fibrillation [letter]. J Am Coll Cardiol 1996; 28:1080-1082
16. 16 Noc M, Stajer D, Horvat M. Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm. Am J Cardiol 1990; 65:679-680
17. 17 Zehender M, Meinertz T, Hohnloser SH, et al. Quinidine, verapamil and amiodarone in chronic atrial fibrillation: which drug for which pattern? Cardiovasc Drugs Ther 1991; 5(suppl 3):360
18. 18 Kochiadakis GE, Igoumenidis NE, Parthenakis FI, et al. Amiodarone versus propafenone for conversion of chronic atrial fibrillation: results of a randomized, controlled study. J Am Coll Cardiol 1999; 33:966-971
19. 19 Jafari-Feshataki M, Scheinman MM. Adverse effects of tamiodarone. PACE 1998; 21:108-120
20. 20 Reiffel JA. Impact of structural heart disease on the selecting of class III antiarrhythmics for the prevention of atrial fibrillation and flutter. Am Heart J 1998; 135:551-556
21. 21 Vorperian VR, Havighurst TC, Miller S, et al. Adverse effects of low-dose amiodarone: a meta-analysis. J Am Coll Cardiol 1997; 30:791-798
22. 22 Massie BM, Fisher SG, Deedwania PC, et al. Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. Circulation 1996; 93: 2129-2134